Meanwhile, recent ASH studies have shown that a combination of CD3-PEBL may function similarly to TRAC knockout, making PBEL-generated universal CD7 CAR T-cells safer and reducing the risk of GvHD. Here, TRAC is linked to graft versus host disease.